1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INNATE PHARMA - ADR

Innate Pharma - ADR

XNAS: IPHA

Download real time

1.88 0.06 (3.30%)

46.44% Fall from 52W High

57,887 XNAS Volume

High volume today

XNAS 11 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
157.6

Market Cap

Below industry Median
-

PE TTM

-

PEG TTM

14.6

Price to Book

High in industry
0.4

Beta 1Year

Very Low volatility
Board Meeting
The board meeting for Innate Pharma - ADR is scheduled for today, for the purpose of Innate Pharma SA Annual Report for 2024 See details


Insider Trading disclosures for Innate Pharma - ADR

There were no Insider Trade disclosures made for Innate Pharma - ADR

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters